Cargando…
Using CRISPR/Cas9 to model human liver disease
CRISPR/Cas9 gene editing has revolutionised biomedical research. The ease of design has allowed many groups to apply this technology for disease modelling in animals. While the mouse remains the most commonly used organism for embryonic editing, CRISPR is now increasingly performed with high efficie...
Autores principales: | Alves-Bezerra, Michele, Furey, Nika, Johnson, Collin G., Bissig, Karl-Dimiter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005665/ https://www.ncbi.nlm.nih.gov/pubmed/32039390 http://dx.doi.org/10.1016/j.jhepr.2019.09.002 |
Ejemplares similares
-
Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia
por: Pankowicz, Francis P., et al.
Publicado: (2016) -
Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease
por: Jarrett, Kelsey E., et al.
Publicado: (2017) -
A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome
por: Kruse, Robert L., et al.
Publicado: (2021) -
A human liver chimeric mouse model for non-alcoholic fatty liver disease
por: Bissig-Choisat, Beatrice, et al.
Publicado: (2021) -
Modeling human disease in rodents by CRISPR/Cas9 genome editing
por: Birling, Marie-Christine, et al.
Publicado: (2017)